Apolipoprotein E E3/E4 genotype is associated with an increased risk of coronary atherosclerosis in patients with

Guoliang Wei1, Bin Li2, Hao Wang2

  • 1Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China. weiguoliangmz@126.com.

BMC Cardiovascular Disorders
|September 11, 2024
PubMed

Insights

The APOE ɛ3/ɛ4 genotype is an independent risk factor for coronary atherosclerosis in hypertensive patients, alongside overweight, advanced age, smoking, diabetes, and hyperlipidemia.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Apolipoprotein E (APOE) gene polymorphisms are linked to coronary atherosclerosis and hypertension.
  • The specific role of APOE polymorphisms in coronary atherosclerosis risk among hypertensive individuals remains unclear.

Purpose of the Study:

  • To investigate the association between APOE gene polymorphisms and the susceptibility to coronary atherosclerosis in patients with hypertension.

Main Methods:

  • Retrospective analysis of 1713 hypertensive patients.
  • Genotyping of APOE rs429358 and rs7412 polymorphisms.
  • Statistical analysis to determine the relationship between APOE genotypes and coronary atherosclerosis risk.

Main Results:

  • The APOE ɛ3/ɛ4 genotype frequency was significantly higher in hypertensive patients with coronary atherosclerosis (16.4%) compared to controls (10.9%).
  • Independent risk factors identified include overweight (BMI ≥ 24.0 kg/m²), advanced age (≥ 65 years), smoking history, diabetes mellitus, and hyperlipidemia.
  • APOE ɛ3/ɛ4 genotype was significantly associated with an increased risk of coronary atherosclerosis (OR: 1.514, 95% CI: 1.133-2.024).

Conclusions:

  • Overweight, advanced age, smoking, diabetes mellitus, and the APOE ɛ3/ɛ4 genotype are independent risk factors for coronary atherosclerosis in hypertensive patients.
  • These findings highlight the importance of genetic predisposition, specifically the APOE ɛ3/ɛ4 genotype, in the development of coronary atherosclerosis within the hypertensive population.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
141
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
26
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.0K